To watch Video

Copy the short URL in each article and paste it new tab

Wednesday, May 6, 2015

Breakingviews: Alexion's pricey play

The rare-disease drugmaker's $8.4 billion bid for rival Synageva includes a 136 percent premium, but Robert Cyran and Reynolds Holding explain why that could make sense.


from Reuters Video: Breakingviews http://ift.tt/1c6emsM
via IFTTT

No comments:

Post a Comment